Bio-Techne Scientist Presented With the CASSS CE Pharm Award

OCTOBER 02, 2018 MINNEAPOLIS, Oct. 2, 2018 /PRNewswire/ — Bio-Techne is proud to announce that one of its Principal Scientists, Jiaqi Wu, Ph.D., was presented with the CE Pharm Award at this year’s CE Pharm meeting, September 9-12, 2018, for his contributions to the capillary electrophoresis (CE) field. Each year since 2006, the CASSS organization has identified an individual... Read more

FLIR Systems Receives Award Totaling $28.7M for the Next Generation Chemical Detector (NGCD) from the United States Army

WILSONVILLE, Ore. – October 1, 2018 – FLIR Systems, Inc. (NASDAQ: FLIR) announced today it has received an award from the United States Department of Defense (DOD) Joint Program Executive Office for Chemical Biological Radiological and Nuclear Defense (JPEO-CBRND) in support of the Multi-Phase Chemical Agent Detector (MPCAD) program. The Other Transaction Authority Agreement (OTA) is... Read more

Thermo Fisher Scientific Showcases Innovations in Proteomic Research at HUPO 2018

Thermo Fisher Scientific Showcases Innovations in Proteomic Research at HUPO 2018 ORLANDO, Fla., Oct. 1, 2018 /PRNewswire/ — HUPO 2018 – Demonstrating its commitment to advancing the performance of protein analysis, Thermo Fisher Scientific is showcasing its latest solutions and technologies at the 17th Human Proteome Organization (HUPO) World Congress (booth #401), September 30-October 3 at the... Read more

Illumina Announces Conversion Period for 0% Convertible Senior Notes due 2019 and 0.5% Convertible Senior Notes due 2021

SAN DIEGO–(BUSINESS WIRE)–Sep. 28, 2018– Illumina, Inc. (Nasdaq: ILMN) (“Illumina” or the “Company”) today notified holders of its 0% Convertible Senior Notes due 2019 (the “2019 Notes”) and its 0.5% Convertible Senior Notes due 2021 (the “2021 Notes” and, together with the 2019 Notes, the “Notes”) that the Notes will become convertible into Illumina common stock at the option... Read more

NanoView Awarded Phase II SBIR Grant from the National Science Foundation

Phase II grant to support development of innovative exosome characterization platform BOSTON, Sept. 27, 2018 /PRNewswire/ — NanoView Biosciences, an emerging leader in the field of exosome characterization, has been awarded a National Science Foundation Small Business Innovation Research Phase II grant in the amount of $750,000. The program will focus on completing development of the ExoView™ system, the company’s... Read more

ZEISS sponsors traveling exhibition showcasing extraordinary images from science

“Images from Science 3” explores interface of science, technology, art, design, and communication Events News ZEISS is sponsoring Images from Science 3, a traveling exhibition celebrating the world’s most extraordinary images and image makers who explore science. The exhibition, a collaboration between Rochester Institute of Technology and Johns Hopkins University, will premier in late November... Read more

FlowCam® Nano Celebrates First Year in the Market with Multiple Awards and Recognitions for Innovation

  Fluid Imaging Technologies’ digital flow imaging nanoparticle analyzer delivers multiple benefits to scientists across industries SCARBOROUGH, Maine, Sept. 27, 2018 /PRNewswire/ — FlowCam® Nano from Fluid Imaging Technologies, Inc. wraps up a remarkable first year in the market with multiple recognitions for breakthrough innovation in laboratory science. It is the only analyzer capable of simultaneously counting, measuring, producing high-resolution digital... Read more

Xylem Inc. to participate at the Cowen Industrial Innovation & Technology Summit

RYE BROOK, N.Y.–(BUSINESS WIRE)–Sep. 19, 2018– Xylem Inc. (NYSE: XYL), a leading global water technology company dedicated to solving the world’s most challenging water issues, announced today that its Senior Vice President and Chief Innovation and Technology Officer Jay Iyengar will participate in a panel entitled Water – Reaching an Inflection in Advanced Technology at... Read more

Reminder: Invitation to Roche's Virtual Pipeline Event: Key data for Roche's lung cancer portfolio to be presented at the 2018 IASLC World Conference on Lung Cancer

Basel, 18 September 2018 Reminder: Invitation to Roche’s Virtual Pipeline Event: Key data for Roche’s lung cancer portfolio to be presented at the 2018 IASLC World Conference on Lung Cancer Agenda Roche lung cancer portfolio key data IMpower133: Primary PFS, OS, and Safety in a Ph1/3 Study of 1L Atezolizumab + Carboplatin + Etoposide in... Read more

IDEX Corporation Named One of America’s Most Trustworthy Companies

September 17, 2018 at 9:00 AM EDT PDF Version LAKE FOREST, Ill.–(BUSINESS WIRE)–Sep. 17, 2018– IDEX Corporation (NYSE: IEX) today announced that the company has been named as one of the nation’s most trustworthy companies. IDEX was one of only 53 large cap companies selected to the annual list of the Most Trustworthy Public Companies in the United States by... Read more